Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1982-6-24
|
pubmed:abstractText |
Glycosylation inhibitors, glucosamine or tunicamycin, have been found to be specific inhibitory modulators for melanogenesis, which is accentuated generally in malignant melanoma cells. Exposure to glucosamine (1 mg/ml) or tunicamycin (0.2 to 0.4 micrograms/ml) induces a marked pigment loss within melanoma cells in vitro with a decrease in their grown curves. This melanogenic inhibition occurs without a substantial decrease in the synthesis of DNA, RNA, and protein in comparison with a specific, marked suppression of carbohydrate synthesis as revealed by suppressed mannose incorporation into these cells. Assay of tyrosinase of glucosamine- or tunicamycin-induced unpigmented melanoma cells has revealed a selective and marked decrease in the melanosome-rich large-granule fraction, but no substantial decrease in the total activity of remaining subcellular fractions. Electrophoresis of tyrosinase in the 30,000 X g supernatant fraction demonstrates an increase in the T1 form of soluble tyrosinase, while a disappearance of or marked decrease in membrane-bound tyrosinase, T3, is seen in the small- and large-granule fractions. Glycoprotein synthesis in the melanogenic subcellular compartments of pigment cells seems to play an integral role in melanogenesis which is principally enhanced in their carcinogenic status.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Catechol Oxidase,
http://linkedlifedata.com/resource/pubmed/chemical/Glucosamine,
http://linkedlifedata.com/resource/pubmed/chemical/Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Mannose,
http://linkedlifedata.com/resource/pubmed/chemical/Melanins,
http://linkedlifedata.com/resource/pubmed/chemical/Monophenol Monooxygenase,
http://linkedlifedata.com/resource/pubmed/chemical/Tunicamycin
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0008-5472
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
42
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1994-2002
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:6802485-Animals,
pubmed-meshheading:6802485-Catechol Oxidase,
pubmed-meshheading:6802485-Cell Fractionation,
pubmed-meshheading:6802485-Cell Membrane,
pubmed-meshheading:6802485-Cells, Cultured,
pubmed-meshheading:6802485-Cricetinae,
pubmed-meshheading:6802485-Electrophoresis,
pubmed-meshheading:6802485-Enzyme Induction,
pubmed-meshheading:6802485-Glucosamine,
pubmed-meshheading:6802485-Glycoproteins,
pubmed-meshheading:6802485-Mannose,
pubmed-meshheading:6802485-Melanins,
pubmed-meshheading:6802485-Melanoma,
pubmed-meshheading:6802485-Mesocricetus,
pubmed-meshheading:6802485-Mice,
pubmed-meshheading:6802485-Monophenol Monooxygenase,
pubmed-meshheading:6802485-Tunicamycin
|
pubmed:year |
1982
|
pubmed:articleTitle |
Loss of melanogenic properties in tyrosinases induced by glucosylation inhibitors within malignant melanoma cells.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|